MML Investors Services’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-11,012
Closed -$366K – 2148
2022
Q2
$366K Sell
11,012
-3,066
-22% -$130K ﹤0.01% 1569
2022
Q1
$1.01M Sell
14,078
-19,630
-58% -$1.41M 0.01% 1087
2021
Q4
$3.1M Buy
33,708
+2,579
+8% +$308K 0.02% 588
2021
Q3
$3.95M Buy
31,129
+4,346
+16% +$633K 0.03% 487
2021
Q2
$4.45M Buy
26,783
+3,911
+17% +$634K 0.04% 430
2021
Q1
$4.16M Buy
22,872
+3,315
+17% +$769K 0.04% 412
2020
Q4
$3.91M Buy
19,557
+7,287
+59% +$1.48M 0.04% 377
2020
Q3
$2.69M Buy
12,270
+3,571
+41% +$756K 0.03% 426
2020
Q2
$1.66M Sell
8,699
-339
-4% -$59.4K 0.02% 561
2020
Q1
$1.4M Buy
9,038
+5,382
+147% +$626K 0.02% 513
2019
Q4
$306K Buy
+3,656
New +$278K ﹤0.01% 1226

Other funds holding TDOC

MML Investors Services's TDOC Position: Q3 2022 in Review

MML Investors Services sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 11,012 shares — an estimated $366K sold.

MML Investors Services first reported a position in TDOC in Q4 2019 and held it in 11 quarters. The position peaked at $4.45M in Q2 2021. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • MML Investors Services reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • MML Investors Services sold 11,012 Teladoc Health shares in Q3 2022, an estimated $366K.
  • MML Investors Services first reported a position in Teladoc Health in Q4 2019 and held it in 11 quarters.
  • MML Investors Services's Teladoc Health position peaked at $4.45M in Q2 2021.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on MML Investors Services's 13F filing for Q3 2022, filed 14 Nov 2022.